Benign Positional Vertigo Market Size, Share & Trends Analysis Report By Therapeutics (Vestibular Function Restoratives, Antivertigo H1 Antihistamines), By Type (Branded, Generic), By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2033
Description
Benign Positional Vertigo Market Summary
The global benign positional vertigo market size was estimated at USD 1.84 billion in 2024 and is projected to reach USD 2.73 billion by 2033, growing at a CAGR of 4.5% from 2025 to 2033. The benign positional vertigo industry is driven by the growing prevalence of vestibular disorders, increased awareness of balance-related conditions, and advancements in diagnostic tools such as videonystagmography (VNG) and magnetic resonance imaging (MRI).
Rising geriatric population prone to inner ear dysfunctions further supports market growth. Expanding use of vestibular rehabilitation therapy and pharmacological treatments, including antihistamines and vestibular suppressants, is contributing to demand. In addition, increasing research on vestibular dysfunction mechanisms is expected to enhance treatment accessibility and adoption.
The rise in vestibular disorders and the growing elderly population drive demand for effective treatment options for benign positional vertigo across a wide patient base. Advances in diagnostic tools, non-invasive therapies, and guided repositioning devices have improved accuracy, patient comfort, and clinical outcomes. Vestibular impairments occur frequently with age, creating a substantial population at risk. According to an article published in the International Journal of Otorhinolaryngology and Head and Neck Surgery in July 2023, the overall prevalence of age-related vestibular loss was reported to be 35.4% among individuals aged over 40 years, highlighting the substantial patient pool requiring targeted interventions.
Global Benign Positional Vertigo Market Report Segmentation
This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the global benign positional vertigo market report based on the therapeutics, type, distribution channel, and region:
The global benign positional vertigo market size was estimated at USD 1.84 billion in 2024 and is projected to reach USD 2.73 billion by 2033, growing at a CAGR of 4.5% from 2025 to 2033. The benign positional vertigo industry is driven by the growing prevalence of vestibular disorders, increased awareness of balance-related conditions, and advancements in diagnostic tools such as videonystagmography (VNG) and magnetic resonance imaging (MRI).
Rising geriatric population prone to inner ear dysfunctions further supports market growth. Expanding use of vestibular rehabilitation therapy and pharmacological treatments, including antihistamines and vestibular suppressants, is contributing to demand. In addition, increasing research on vestibular dysfunction mechanisms is expected to enhance treatment accessibility and adoption.
The rise in vestibular disorders and the growing elderly population drive demand for effective treatment options for benign positional vertigo across a wide patient base. Advances in diagnostic tools, non-invasive therapies, and guided repositioning devices have improved accuracy, patient comfort, and clinical outcomes. Vestibular impairments occur frequently with age, creating a substantial population at risk. According to an article published in the International Journal of Otorhinolaryngology and Head and Neck Surgery in July 2023, the overall prevalence of age-related vestibular loss was reported to be 35.4% among individuals aged over 40 years, highlighting the substantial patient pool requiring targeted interventions.
Global Benign Positional Vertigo Market Report Segmentation
This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the global benign positional vertigo market report based on the therapeutics, type, distribution channel, and region:
- Therapeutics Outlook (Revenue, USD Million, 2021 - 2033)
- Vestibular Function Restoratives
- Antivertigo H1 Antihistamines
- Benzodiazepines
- Others
- Type Outlook (Revenue, USD Million, 2021 - 2033)
- Branded
- Generic
- Distribution Channel Outlook (Revenue, USD Million, 2021 - 2033)
- Hospital Pharmacies
- Online Pharmacies
- Other
- Regional Outlook (Revenue, USD Million, 2021 - 2033)
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Thailand
- Latin America
- Brazil
- Argentina
- MEA
- South Africa
- Saudi Arabia
- UAE
- Kuwait
Table of Contents
150 Pages
- Chapter 1. Methodology and Scope
- 1.1 Market Segmentation & Scope
- 1.2 Segment Definitions
- 1.2.1 Therapeutics
- 1.2.2 Type
- 1.2.3 Distribution Channel
- 1.3 Research Methodology
- 1.4 Information Procurement
- 1.4.1 Purchased database
- 1.4.2 GVR’s internal database
- 1.4.3 Secondary sources
- 1.4.4 Primary research
- 1.5 Information or Data Analysis
- 1.5.1 Data analysis models
- 1.6 Market Formulation & Validation
- 1.7 Model Details
- 1.8 List of Secondary Sources
- 1.9 List of Primary Sources
- 1.10 Objectives
- Chapter 2 Executive Summary
- 2.1 Market Outlook
- 2.2 Segment Snapshot
- 2.3 Competitive Insights Landscape
- Chapter 3 Benign Positional Vertigo Market Variables, Trends & Scope
- 3.1 Market Lineage Outlook
- 3.1.1 Parent market outlook
- 3.1.2 Related/ancillary market outlook.
- 3.2 Market Dynamics
- 3.2.1 Market driver analysis
- 3.2.2 Market restraint analysis
- 3.3 Benign Positional Vertigo Market Analysis Tools
- 3.3.1 Industry Analysis - Porter’s
- 3.3.2 PESTEL Analysis
- Chapter 4 Benign Positional Vertigo Market: Therapeutics Estimates & Trend Analysis
- 4.1 Segment Dashboard
- 4.2 Benign Positional Vertigo Market Therapeutics Movement Analysis
- 4.3 Benign Positional Vertigo Market Size & Trend Analysis, by Therapeutics, 2021 to 2033 (USD Million)
- 4.4 Vestibular Function Restoratives
- 4.4.1 Vestibular function restoratives market estimates and forecasts, 2021 to 2033 (USD Million)
- 4.5 Antivertigo H1 Antihistamines
- 4.5.1 Antivertigo H1 antihistamines market estimates and forecasts, 2021 to 2033 (USD Million)
- 4.6 Benzodiazepines
- 4.6.1 Benzodiazepines market estimates and forecasts, 2021 to 2033 (USD Million)
- 4.7 Others
- 4.7.1 Others market estimates and forecasts, 2021 to 2033 (USD Million)
- Chapter 5 Benign Positional Vertigo Market: Type Estimates & Trend Analysis
- 5.1 Segment Dashboard
- 5.2 Benign Positional Vertigo Market Type Movement Analysis
- 5.3 Benign Positional Vertigo Market Size & Trend Analysis, by Type, 2021 to 2033 (USD Million)
- 5.4 Branded
- 5.4.1 Branded market estimates and forecasts, 2021 to 2033 (USD Million)
- 5.5 Generic
- 5.5.1 Generic market estimates and forecasts, 2021 to 2033 (USD Million)
- Chapter 6 Benign Positional Vertigo Market: Distribution Channel Estimates & Trend Analysis
- 6.1 Segment Dashboard
- 6.2 Benign Positional Vertigo Market Distribution Channel Movement Analysis
- 6.3 Benign Positional Vertigo Market Size & Trend Analysis, by Distribution Channel, 2021 to 2033 (USD Million)
- 6.4 Hospital Pharmacies
- 6.4.1 Hospital pharmacies market estimates and forecasts, 2021 to 2033 (USD Million)
- 6.5 Online Pharmacies
- 6.5.1 Online pharmacies market estimates and forecasts, 2021 to 2033 (USD Million)
- 6.6 Others
- 6.6.1 Others market estimates and forecasts, 2021 to 2033 (USD Million)
- Chapter 7 Benign Positional Vertigo Market: Regional Estimates & Trend Analysis
- 7.1 Regional Market Share Analysis, 2024 & 2033
- 7.2 Regional Market Dashboard
- 7.3 Market Size, & Forecasts Trend Analysis, 2021 to 2033:
- 7.4 North America
- 7.4.1 U.S.
- 7.4.1.1 Key country dynamics
- 7.4.1.2 U.S. market estimates and forecasts, 2021 to 2033 (USD Million)
- 7.4.2 Canada
- 7.4.2.1 Key country dynamics
- 7.4.2.2 Canada market estimates and forecasts, 2021 to 2033 (USD Million)
- 7.4.3 Mexico
- 7.4.3.1 Key country dynamics
- 7.4.3.2 Mexico market estimates and forecasts, 2021 to 2033 (USD Million)
- 7.5 Europe
- 7.5.1 UK
- 7.5.1.1 Key country dynamics
- 7.5.1.2 UK market estimates and forecasts, 2021 to 2033 (USD Million)
- 7.5.2 Germany
- 7.5.2.1 Key country dynamics
- 7.5.2.2 Germany market estimates and forecasts, 2021 to 2033 (USD Million)
- 7.5.3 France
- 7.5.3.1 Key country dynamics
- 7.5.3.2 France market estimates and forecasts, 2021 to 2033 (USD Million)
- 7.5.4 Italy
- 7.5.4.1 Key country dynamics
- 7.5.4.2 Italy market estimates and forecasts, 2021 to 2033 (USD Million)
- 7.5.5 Spain
- 7.5.5.1 Key country dynamics
- 7.5.5.2 Spain market estimates and forecasts, 2021 to 2033 (USD Million)
- 7.5.6 Norway
- 7.5.6.1 Key country dynamics
- 7.5.6.2 Norway market estimates and forecasts, 2021 to 2033 (USD Million)
- 7.5.7 Sweden
- 7.5.7.1 Key country dynamics
- 7.5.7.2 Sweden market estimates and forecasts, 2021 to 2033 (USD Million)
- 7.5.8 Denmark
- 7.5.8.1 Key country dynamics
- 7.5.8.2 Denmark market estimates and forecasts, 2021 to 2033 (USD Million)
- 7.6 Asia Pacific
- 7.6.1 Japan
- 7.6.1.1 Key country dynamics
- 7.6.1.2 Japan market estimates and forecasts, 2021 to 2033 (USD Million)
- 7.6.2 China
- 7.6.2.1 Key country dynamics
- 7.6.2.2 China market estimates and forecasts, 2021 to 2033 (USD Million)
- 7.6.3 India
- 7.6.3.1 Key country dynamics
- 7.6.3.2 India market estimates and forecasts, 2021 to 2033 (USD Million)
- 7.6.4 Australia
- 7.6.4.1 Key country dynamics
- 7.6.4.2 Australia market estimates and forecasts, 2021 to 2033 (USD Million)
- 7.6.5 South Korea
- 7.6.5.1 Key country dynamics
- 7.6.5.2 South Korea market estimates and forecasts, 2021 to 2033 (USD Million)
- 7.6.6 Thailand
- 7.6.6.1 Key country dynamics
- 7.6.6.2 Thailand market estimates and forecasts, 2021 to 2033 (USD Million)
- 7.7 Latin America
- 7.7.1 Brazil
- 7.7.1.1 Key country dynamics
- 7.7.1.2 Brazil market estimates and forecasts, 2021 to 2033 (USD Million)
- 7.7.2 Argentina
- 7.7.2.1 Key country dynamics
- 7.7.2.2 Argentina market estimates and forecasts, 2021 to 2033 (USD Million)
- 7.8 MEA
- 7.8.1 South Africa
- 7.8.1.1 Key country dynamics
- 7.8.1.2 South Africa market estimates and forecasts, 2021 to 2033 (USD Million)
- 7.8.2 Saudi Arabia
- 7.8.2.1 Key country dynamics
- 7.8.2.2 Saudi Arabia market estimates and forecasts, 2021 to 2033 (USD Million)
- 7.8.3 UAE
- 7.8.3.1 Key country dynamics
- 7.8.3.2 UAE market estimates and forecasts, 2021 to 2033 (USD Million)
- 7.8.4 Kuwait
- 7.8.4.1 Key country dynamics
- 7.8.4.2 Kuwait market estimates and forecasts, 2021 to 2033 (USD Million)
- Chapter 8 Competitive Landscape
- 8.1 Company/Competition Categorization
- 8.2 Strategy Mapping
- 8.3 Company Market Position Analysis, 2024
- 8.4 Company Profiles/Listing
- 8.4.1 Viatris Inc.
- 8.4.1.1 Company overview
- 8.4.1.2 Financial performance
- 8.4.1.3 Product benchmarking
- 8.4.1.4 Strategic initiatives
- 8.4.2 Pfizer Inc.
- 8.4.2.1 Company overview
- 8.4.2.2 Financial performance
- 8.4.2.3 Product benchmarking
- 8.4.2.4 Strategic initiatives
- 8.4.3 Zydus Group
- 8.4.3.1 Company overview
- 8.4.3.2 Financial performance
- 8.4.3.3 Product benchmarking
- 8.4.3.4 Strategic initiatives
- 8.4.4 Prestige Consumer Healthcare Inc
- 8.4.4.1 Company overview
- 8.4.4.2 Financial performance
- 8.4.4.3 Product benchmarking
- 8.4.4.4 Strategic initiatives
- 8.4.5 GSK plc
- 8.4.5.1 Company overview
- 8.4.5.2 Financial performance
- 8.4.5.3 Product benchmarking
- 8.4.5.4 Strategic initiatives
- 8.4.6 Novartis AG
- 8.4.6.1 Company overview
- 8.4.6.2 Financial performance
- 8.4.6.3 Product benchmarking
- 8.4.6.4 Strategic initiatives
- 8.4.7 Johnson & Johnson
- 8.4.7.1 Company overview
- 8.4.7.2 Financial performance
- 8.4.7.3 Product benchmarking
- 8.4.7.4 Strategic initiatives
- 8.4.8 Teva Pharmaceutical Industries Ltd.
- 8.4.8.1 Company overview
- 8.4.8.2 Financial performance
- 8.4.8.3 Product benchmarking
- 8.4.8.4 Strategic initiatives
- 8.4.9 Sun Pharmaceutical Industries Ltd.
- 8.4.9.1 Company overview
- 8.4.9.2 Financial performance
- 8.4.9.3 Product benchmarking
- 8.4.9.4 Strategic initiatives
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
